Publication number: 20040156846
Abstract: Methods for treating cells, diseased tissue, pathogens, or other undesirable matter involve the administration of a bioprobe (energy susceptive materials that are attached to the target-specific ligand chimeric L6 antibody) to a patient's body, body part, tissue, or body fluid (such as blood, blood plasma, or blood serum). An energy source provides energy to the bioprobe so as to destroy, rupture, or inactivate the target. Various energy forms, such as AMF, microwave, acoustic, or a combination thereof, created via a variety of mechanisms, may be used. The disclosed methods may be useful in the treatment of a variety of indications, including but not limited to, cancer of any type, such as bone marrow, lung, vascular, neuro, colon, ovarian, breast and prostate cancer.
Type:
Application
Filed:
February 6, 2003
Publication date:
August 12, 2004
Applicant:
Triton Biosystems, Inc.
Inventors:
Wolfgang Daum, Gerald DeNardo, Diane Ellis-Busby, Alan Foreman, Douglas U. Gwost, Erik Schroeder Handy, Robert Ivkov